(JCE) Nuveen Core Equity Alpha - Ratings and Ratios
Exchange: NYSE • Country: USA • Currency: USD • Type: Fund • ISIN: US67090X1072 • Large Growth
JCE: Stocks, Bonds, Equities, Securities
Additional Sources for JCE Fund
News:
Wall Street Journal
Benzinga
Yahoo Finance
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
JCE Fund Overview
| Market Cap in USD | 254m |
| Style | Large Growth |
| TER | 0.98% |
| IPO / Inception | 2007-03-27 |
JCE Fund Ratings
| Growth 5y | 73.0% |
| Fundamental | - |
| Dividend | 84.7% |
| Rel. Strength Industry | 2.72 |
| Analysts | - |
| Fair Price Momentum | 16.31 USD |
| Fair Price DCF | - |
JCE Dividends
| Dividend Yield 12m | 8.44% |
| Yield on Cost 5y | 14.97% |
| Annual Growth 5y | 6.71% |
| Payout Consistency | 87.4% |
JCE Growth Ratios
| Growth Correlation 3m | 84.6% |
| Growth Correlation 12m | 97.5% |
| Growth Correlation 5y | 83.5% |
| CAGR 5y | 13.27% |
| CAGR/Max DD 5y | 0.33 |
| Sharpe Ratio 12m | 1.42 |
| Alpha | 8.87 |
| Beta | 0.79 |
| Volatility | 11.52% |
| Current Volume | 22.4k |
| Average Volume 20d | 23.2k |
What is the price of JCE stocks?
As of February 22, 2025, the stock is trading at USD 15.96 with a total of 22,366 shares traded.
Over the past week, the price has changed by -1.12%, over one month by +0.69%, over three months by +5.28% and over the past year by +27.72%.
As of February 22, 2025, the stock is trading at USD 15.96 with a total of 22,366 shares traded.
Over the past week, the price has changed by -1.12%, over one month by +0.69%, over three months by +5.28% and over the past year by +27.72%.
Is Nuveen Core Equity Alpha a good stock to buy?
Yes. Based on ValueRay Analyses, Nuveen Core Equity Alpha (NYSE:JCE) is currently (February 2025) a good stock to buy. It has a ValueRay Growth Rating of 73.02 and therefor a clear technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of JCE as of February 2025 is 16.31. This means that JCE is currently overvalued and has a potential downside of 2.19%.
Yes. Based on ValueRay Analyses, Nuveen Core Equity Alpha (NYSE:JCE) is currently (February 2025) a good stock to buy. It has a ValueRay Growth Rating of 73.02 and therefor a clear technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of JCE as of February 2025 is 16.31. This means that JCE is currently overvalued and has a potential downside of 2.19%.
Is JCE a buy, sell or hold?
Nuveen Core Equity Alpha has no consensus analysts rating.
Nuveen Core Equity Alpha has no consensus analysts rating.
What are the forecast for JCE stock price target?
According to ValueRays Forecast Model, JCE Nuveen Core Equity Alpha will be worth about 19.5 in February 2026. The stock is currently trading at 15.96. This means that the stock has a potential upside of +22.24%.
According to ValueRays Forecast Model, JCE Nuveen Core Equity Alpha will be worth about 19.5 in February 2026. The stock is currently trading at 15.96. This means that the stock has a potential upside of +22.24%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 19.5 | 22.2% |